Understanding the new HbA 1c units for the diagnosis of type 2 diabetes

New Zealand Medical Journal

Volumn 125, Issue 1362, 2012, Pages 70-80

  Braatvedt, Geoff D ^a   Cundy, Tim ^a   Crooke, Michael ^b   Florkowski, Chris ^c   Mann, Jim I ^d   Lunt, Helen ^e   Jackson, Rod ^f   Orr Walker, Brandon ^g   Kenealy, Timothy ^a   Drury, Paul L ^h  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b WELLINGTON HOSPITAL   (New Zealand)

^c CANTERBURY HEALTH LABORATORIES   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

^f THE UNIVERSITY OF AUCKLAND   (New Zealand)

^g MIDDLEMORE HOSPITAL   (New Zealand)

^h GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; CARDIOVASCULAR RISK; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; LABORATORY DIAGNOSIS; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; REPEAT PROCEDURE; RETINOPATHY; RISK ASSESSMENT; SCREENING TEST; BLOOD; CORONARY ARTERY DISEASE; GLUCOSE TOLERANCE TEST; INTERNATIONAL STANDARD UNIT; NEW ZEALAND; PATIENT COMPLIANCE; STANDARD; STATISTICS;

BLOOD GLUCOSE; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERNATIONAL SYSTEM OF UNITS; LIFE STYLE; NEW ZEALAND; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; REFERENCE STANDARDS; RISK ASSESSMENT;

EID: 84866889271     PISSN: 00288446     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Mayfield J. Diagnosis and classification of diabetes mellitus; new criteria. Diabetes Care. 1997; 20:1183-1197.
2. Technical report of WHO 1999 Part 1: Definition, diagnosis and classification of diabetes and its complications. http://www.staff.ncl.ac.uk/philip.home/who_dmg.pdf
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011; 34: S62-S69.
4. Goldenberg RM, Cheng AYY, Punthakee Z, Clement M Position statement. Use of glycatedhemoblobin (A1C) in the diagnosis of type 2 diabetes mellitus in adults. Canadian Journal of Diabetes. 2011;35:247-249.
5. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes. Abbreviated report of a WHO consultation. World Health Organization; 2011.
6. Hanas R and John G on behalf of the International HbA1c Consensus Committee. 2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1c Measurement. Diabet Med. 2010;27:737-738.
7. www.nzssd.org.nz
8. Little RR, Rohlfing CL and Sacks DB. Status of Hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem. 2011;57:205-215.
9. Wilson DM, Xing D, Beck RW, et al. Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Care. 2011; 34:540-544.
10. Colagirui S, Lee CMY, Wong TY, et al. Glycemic thresholds for diabetes-specific retinopathy.Implications for diagnostic criteria for diabetes. Diabetes Care. 2011; 34:145-150.
11. Braatvedt GD, Gamble G, Kyle C. Metabolic characteristics of patients with apparently normal blood glucose. NZ Med J. 2006;119:U2123.
12. New Zealand Guidelines Group. New Zealand cardiovascular guidelines handbook: A summary resource for primary care practitioners, 2nd Edn. Wellington: New Zealand Guidelines Group 2009. www.nzgg.org.nz
13. Ko GTC, Chan JCN, Woo J, et al. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem. 1998;35: 62-7.
14. Mooy J, Grootehuis P, de Vries H, et al. Intra-individual variation of glucose, specific insulin and pro-insulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia. 1996;39: 298-305.
15. http://www.westgard.com/biodatabase1.htm
16. http://www.rcpaqap.com.au
17. Chan AYW, Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989;35:315-317.
18. Sacks DB, Arnold M, Bakris GL et al. Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2011;341419-1423.
19. Takahashi OT, Farmer AJ, Shimbo T, Fukui T, Glasziou PP. A1C to detect diabetes in healthy adults. When should we recheck? Diabetes Care. 2010; 33: 2016-2017.
20. Elley CR, Kenealy T, Robinson E, Drury PL. Glycated haemoglobin and cardiovascular outcomes in people with Type 2 diabetes: a large prospective cohort study. Diabet Med. 2008; 25 (11): 1295-1301.
21. Elley CR., Robinson E, Kenealy T, Bramley D, Drury PL. Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: The New Zealand diabetes cohort study. Diabetes Care. 2010;33:1347-1352.
22. Selvin E, Steffes MW, Zhu H, et al Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults. N Engl J Med. 2010; 362: 800-811.
23. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004; 141(6): 421-431.
24. Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care. 2011; 34: S184-S190.
25. Yudkin JS, Forrest RD, Jackson CA, et al. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia. 1990;33:208-215.
26. Hempe J, Gomez R, McCarter R, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications. 2002;16:313-320.
27. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1c levels. Ann Intern Med. 2010;152:770-777.
28. Kumar PR, Bhansali A, Ravikiran M, et al. Utility of Glycated Hemoglobin in Diagnosing Type 2 Diabetes Mellitus: A Community-Based Study. J Clin Endocrinol Metab. 2010;95:2832-2835.
29. Mostafa SA, Davies MJ, Webb D, et al. The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus. Diabet Med. 2010;27:762-769.
30. Costa B, Barrio F, Cabré J-J, et al. Shifting from glucose diagnostic criteria to the new HbA1c criteria would have a profound impact on prevalence of diabetes among a high-risk Spanish population. Diabet Med. 2011; 28: 1234-1237.
31. Zhou X, Pang Z, Gao W, et al. Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes by an oral glucose tolerance test in Qingdao, China. Diabetes Care. 2010;33:545-550.
32. Mohan V, Vijayachandrika V, Gokulakrishnan K, et al. A1C cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care. 2010;33:515-519.
33. Carretero OA, Oparil S.Essential hypertension: Part 1-definition and aetiology. Circulation. 2000; 101:325-9.
34. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement for Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089-100.
35. Lim EL, Hollingsworth KG, Aribisala BS, et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54:2506-14.
36. Buse JR, Caprio S, Cefalu WT, et al. Consensus statement - How do we define cure of diabetes? Diabetes Care. 2009;32:2133-5.